Back to LYEL

JPMORGAN CHASE & CO → LYEL

JPMORGAN CHASE & CO LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
8
Latest value
$427K
Q3 2026
Peak value
$427K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$8K
Q4 2025$50K
Q1 2026$28K
Q2 2026$50K
Q2 2026$11K
Q3 2026$39K
Q3 2026$12K
Q3 2026$427K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$427K44.3K——
Q3 2026$12K1.3K——
Q3 2026$39K4.0K——
Q2 2026$11K895——
Q2 2026$50K3.9K——
Q1 2026$28K1.5K——
Q4 2025$50K1.6K——
Q3 2025$8K490——

Other funds holding LYEL

Other JPMORGAN CHASE & CO positions

NVDA

NVIDIA CORPORATION

$62.5B
NVDA

NVIDIA CORPORATION

$56.9B
NVDA

NVIDIA CORPORATION

$56.9B
NVDA

NVIDIA CORPORATION

$56.2B
NVDA

NVIDIA CORPORATION

$53.3B
MSFT

MICROSOFT CORP

$52.3B
MSFT

MICROSOFT CORP

$52.3B
MSFT

MICROSOFT CORP

$49.4B